Satellos Bioscience Stock Performance
| MSCLF Stock | USD 0.90 0.04 4.65% |
On a scale of 0 to 100, Satellos Bioscience holds a performance score of 15. The entity has a beta of -0.34, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Satellos Bioscience are expected to decrease at a much lower rate. During the bear market, Satellos Bioscience is likely to outperform the market. Please check Satellos Bioscience's value at risk and the relationship between the expected short fall and price action indicator , to make a quick decision on whether Satellos Bioscience's existing price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Satellos Bioscience are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Satellos Bioscience reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 717.5 K | |
| Total Cashflows From Investing Activities | 1.7 M |
Satellos |
Satellos Bioscience Relative Risk vs. Return Landscape
If you would invest 55.00 in Satellos Bioscience on October 29, 2025 and sell it today you would earn a total of 35.00 from holding Satellos Bioscience or generate 63.64% return on investment over 90 days. Satellos Bioscience is currently producing 0.9347% returns and takes up 4.8088% volatility of returns over 90 trading days. Put another way, 43% of traded otc stocks are less volatile than Satellos, and 82% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Satellos Bioscience Target Price Odds to finish over Current Price
The tendency of Satellos OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.90 | 90 days | 0.90 | near 1 |
Based on a normal probability distribution, the odds of Satellos Bioscience to move above the current price in 90 days from now is near 1 (This Satellos Bioscience probability density function shows the probability of Satellos OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Satellos Bioscience has a beta of -0.34. This indicates as returns on the benchmark increase, returns on holding Satellos Bioscience are expected to decrease at a much lower rate. During a bear market, however, Satellos Bioscience is likely to outperform the market. Additionally Satellos Bioscience has an alpha of 0.9277, implying that it can generate a 0.93 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Satellos Bioscience Price Density |
| Price |
Predictive Modules for Satellos Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Satellos Bioscience. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Satellos Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Satellos Bioscience is not an exception. The market had few large corrections towards the Satellos Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Satellos Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Satellos Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.93 | |
β | Beta against Dow Jones | -0.34 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | 0.18 |
Satellos Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Satellos Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Satellos Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Satellos Bioscience has some characteristics of a very speculative penny stock | |
| Satellos Bioscience appears to be risky and price may revert if volatility continues | |
| Satellos Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (793.97 K). | |
| Satellos Bioscience has accumulated about 1.93 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. |
Satellos Bioscience Fundamentals Growth
Satellos OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Satellos Bioscience, and Satellos Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Satellos OTC Stock performance.
| Return On Equity | -0.86 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 7.17 M | |||
| Shares Outstanding | 41.8 M | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 295.34 X | |||
| EBITDA | (4.49 M) | |||
| Cash And Equivalents | 1.93 M | |||
| Cash Per Share | 0.06 X | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (5.03 M) | |||
| Earnings Per Share | (0.47) X | |||
| Total Asset | 12.59 M | |||
About Satellos Bioscience Performance
By analyzing Satellos Bioscience's fundamental ratios, stakeholders can gain valuable insights into Satellos Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Satellos Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Satellos Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Satellos Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Satellos Bioscience performance evaluation
Checking the ongoing alerts about Satellos Bioscience for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Satellos Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Satellos Bioscience has some characteristics of a very speculative penny stock | |
| Satellos Bioscience appears to be risky and price may revert if volatility continues | |
| Satellos Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (793.97 K). | |
| Satellos Bioscience has accumulated about 1.93 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. |
- Analyzing Satellos Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Satellos Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Satellos Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Satellos Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Satellos Bioscience's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Satellos Bioscience's otc stock. These opinions can provide insight into Satellos Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Satellos OTC Stock analysis
When running Satellos Bioscience's price analysis, check to measure Satellos Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Satellos Bioscience is operating at the current time. Most of Satellos Bioscience's value examination focuses on studying past and present price action to predict the probability of Satellos Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Satellos Bioscience's price. Additionally, you may evaluate how the addition of Satellos Bioscience to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |